0 followers
Tough on #Cancer not on Patients. Initiating Phase II trials on the Indenoisoquinolines, a new class of non-Camptothecins a novel anti-cancer fighting drug.
Randall B Riggs
Merck
231 followers
CHDI Foundation
5 followers
Thermo Fisher Scientific
180 followers
Genentech
163 followers
Gilead Sciences
136 followers
Agilent Technologies
72 followers
Roivant Sciences
56 followers
Apollo Global Management
40 followers
BioMarin Pharmaceutical
37 followers
Verily Life Sciences
38 followers
Myriad Genetics
37 followers
Explore companies